Table 5.
Multivariate analysis for NAFLD according to urinary bisphenol A levels
| Crude | Model 1 | Model 2 | Model 3 | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Quartile 1 | 1 | 0.002* | 1 | 0.035* | 1 | 0.003* | 1 | 0.010* |
| Quartile 2 | 1.01 (0.74-1.39) | 0.913 | 1.00 (0.73-1.37) | 0.955 | 1.09 (0.87-1.36) | 0.435 | 1.08 (0.85-1.36) | 0.510 |
| Quartile 3 | 1.22 (0.89-1.68) | 0.203 | 1.16 (0.84-1.58) | 0.346 | 1.28 (1.02-1.60) | 0.032 | 1.31 (1.03-1.67) | 0.025 |
| Quartile 4 | 1.47 (1.11-1.94) | 0.006 | 1.31 (0.99-1.75) | 0.058 | 1.37 (1.08-1.73) | 0.007 | 1.32 (1.03-1.70) | 0.026 |
NAFLD nonalcoholic fatty liver disease, OR odds ratio, CI confidence interval
*p values were shown the test of trend of odds
Crude: Hepatic steatosis index, bisphenol A
Model 1: Crude + age, gender, creatinine
Model 2: Model 1 + smoking, drinking, exercise, marital status, education, income
Model 3: Model 2 + hypertension, diabetes mellitus, hyperlipidemia